Table 1. Additional Patients' Information.
| Sr. No. | 1 | 2 | 3 | 4 |
|---|---|---|---|---|
| Age at Entry | 66 | 51 | 60 | 72 |
| RhLF Dose | 9 g/day | 9 g/day | 9 g/day | 9 g/day |
| Histology | Clear cell | Clear cell | Clear, Spindle cell | Clear cell |
| Previous Therapy | nephrectomy | nephrectomy, IL-2, interferon-α | nephrectomy, IL2, interferon-α, methionine restriction | nephrectomy, Capecitabine, Gemcitabine, interferon-α, thalidomide |
| MSKCC Risk | Low | Low | Low | Low |
| Patient Status | Alive after 6 years | Alive after 5.5 years | Alive after 7.5 years | Died after 37 months |
| PFS (Months) | 35 | 50 | 35 | 34 |